Business

Apmonia Therapeutics is a biotech company committed to develop therapeutic strategies towards multiple types of cancer. They are developing a first-in-class pipeline of next-generation peptide-based therapies targeting the tumor microenvironment to improve the lives of patients with cancer.

Artialis offers customized solutions and support from preclinical to post-marketing clinical phases, as well as a wide range of clinical, imaging and biochemical markers to support product development.

BelmaTechnologies produces and distributes new implants for laboratory animals (estrogen, progesterone and testosterone).

Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.

CMD-COAT SA is a spin-off company of GIGA/ULiège dedicated to developing a bioactive coating to prevent infection and thrombosis of catheters.

Dendrogenix develop first-in-class molecules, Dendrogenins, to address high unmet medical needs in hearing loss and neurology

Hephaistos Pharma specializes in molecules designed to boost immunotherapies. 

LiveDrop is a droplet microfluidics company whose mission is to develop and offer all-in-one integrated flow cytometers based on droplet microfluidics to boost your cell biology and microbiology studies.

Quidditas Therapeutics developed an alternative technology which permits an absolute genetic recombination. Compatible with a larger scope of applications, from bioprocess improvement to genetic disorders treatment, this revolutionary technique will have a major impact in the Biotechnology field.

THERAtRAME is a spin-off company of GIGA/ULiège which discovers and develops new small molecule inhibitors targeting the tRNA epitranscriptomics to cure patients with untreatable cancer. 

A sports medicine company developing the next generation of orthobiologics to accelerate recover, rehab and return to play.

XeroThera is a clinical stage company leveraging decades of scientific and business leadership in biomaterials to commercialize a patented drug delivery technology to prevent deadly surgical site infections (SSIs) and control surgical pain.